Skip to main content

Meditech news:


Abbott launches drug eluting bioresorbable vascular scaffold in India --- It dissolves into the body over time (within one year,). so, the  treated vessel  resume its  natural function and movement - the potential to flex, pulsate and dilate in response to normal activities such as exercise,more freely because it is free of a permanent metallic stent. Abbott’s BVS is made of polylactide, used also as  dissolving sutures.


critical care in india in critical condition. what to do ?
just 70,000 well equipped ICU beds against an estimated demand of 400,000 ICU beds to provide critical care for approximately five million ICU cases per year  .  equally alarming to see the non-availability of qualified intensive care specialists.so,in this backdrop- a new hope to bridge the gaps. 

Intensive care goes live through CritiNext eICU system.


Comments